Research progress of erythropoietin in the treatment of diabetic retinopathy
Diabetic retinopathy(DR)is the most common complication of diabetes mellitus and remains the leading cause of blindness in working-age population. DR affects almost all the retinal cells, leading to the disruption and dysfunction of neurovascular unit and the neural-glial network. Erythropoietin(EPO...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2021-09-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2021/9/202109009.pdf |
_version_ | 1818694090611490816 |
---|---|
author | Dan-Dan Liu Guo-Tong Xu Jing-Fa Zhang |
author_facet | Dan-Dan Liu Guo-Tong Xu Jing-Fa Zhang |
author_sort | Dan-Dan Liu |
collection | DOAJ |
description | Diabetic retinopathy(DR)is the most common complication of diabetes mellitus and remains the leading cause of blindness in working-age population. DR affects almost all the retinal cells, leading to the disruption and dysfunction of neurovascular unit and the neural-glial network. Erythropoietin(EPO), a glycoprotein hormone, plays a pivotal role in neuroprotection, neurotrophy, anti-inflammation, anti-apoptosis and anti-oxidation etc., in various central nervous system diseases. This review discussed the protective effect of EPO in DR so as to provide new options for DR treatment. |
first_indexed | 2024-12-17T13:24:03Z |
format | Article |
id | doaj.art-05f7acd33ad6453e93983355ae33cf58 |
institution | Directory Open Access Journal |
issn | 1672-5123 |
language | English |
last_indexed | 2024-12-17T13:24:03Z |
publishDate | 2021-09-01 |
publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
record_format | Article |
series | Guoji Yanke Zazhi |
spelling | doaj.art-05f7acd33ad6453e93983355ae33cf582022-12-21T21:46:46ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51232021-09-012191539154210.3980/j.issn.1672-5123.2021.9.09202109009Research progress of erythropoietin in the treatment of diabetic retinopathyDan-Dan Liu0Guo-Tong Xu1Jing-Fa Zhang2Tongji University School of Medicine;Tongji Eye Institute, Shanghai 200092, ChinaTongji University School of Medicine;Tongji Eye Institute, Shanghai 200092, ChinaDepartment of Ophthalmology, Shanghai General Hospital;Shanghai First People's Hospital, Shanghai 200080, ChinaDiabetic retinopathy(DR)is the most common complication of diabetes mellitus and remains the leading cause of blindness in working-age population. DR affects almost all the retinal cells, leading to the disruption and dysfunction of neurovascular unit and the neural-glial network. Erythropoietin(EPO), a glycoprotein hormone, plays a pivotal role in neuroprotection, neurotrophy, anti-inflammation, anti-apoptosis and anti-oxidation etc., in various central nervous system diseases. This review discussed the protective effect of EPO in DR so as to provide new options for DR treatment.http://ies.ijo.cn/cn_publish/2021/9/202109009.pdfdiabetic retinopathyerythropoietinneurovascular unitneural-glial network |
spellingShingle | Dan-Dan Liu Guo-Tong Xu Jing-Fa Zhang Research progress of erythropoietin in the treatment of diabetic retinopathy Guoji Yanke Zazhi diabetic retinopathy erythropoietin neurovascular unit neural-glial network |
title | Research progress of erythropoietin in the treatment of diabetic retinopathy |
title_full | Research progress of erythropoietin in the treatment of diabetic retinopathy |
title_fullStr | Research progress of erythropoietin in the treatment of diabetic retinopathy |
title_full_unstemmed | Research progress of erythropoietin in the treatment of diabetic retinopathy |
title_short | Research progress of erythropoietin in the treatment of diabetic retinopathy |
title_sort | research progress of erythropoietin in the treatment of diabetic retinopathy |
topic | diabetic retinopathy erythropoietin neurovascular unit neural-glial network |
url | http://ies.ijo.cn/cn_publish/2021/9/202109009.pdf |
work_keys_str_mv | AT dandanliu researchprogressoferythropoietininthetreatmentofdiabeticretinopathy AT guotongxu researchprogressoferythropoietininthetreatmentofdiabeticretinopathy AT jingfazhang researchprogressoferythropoietininthetreatmentofdiabeticretinopathy |